Johnson & Johnson JNJ
NYSE JNJ
$261.49 +5.00 (+1.95%)
At close: Oct 9, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Non Operating Interest Expenses (2009 - 2026)

Updated

Johnson & Johnson's Non Operating Interest Expenses was $281 million in Q2 2026, down 8.8% from $308 million a year earlier but up 3.3% from the prior quarter.

Analysis

Johnson & Johnson (JNJ) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Johnson & Johnson's Non Operating Interest Expenses was $1.01 billion through Jun 28, 2026, up 20.2% year-over-year; for FY2025, it came in at $971 million, up 28.6% from FY2024.

  • Non Operating Interest Expenses shows a four-year compound annual growth rate of 48.3% (FY2021 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $755 million in FY2024 (-2.2%), $772 million in FY2023 (+179.7%), $276 million in FY2022 and $201 million in FY2021.
  • Quarterly Non Operating Interest Expenses has moved between $137 million (Q4 2024) and $308 million (Q2 2025) over five years.
  • Compared with a year earlier, Non Operating Interest Expenses was higher in six of the last eight quarters, with growth averaging 18.1%.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q4 2025 (growth of 56.2%); the worst was Q1 2024 (a decline of 26.9%).
  • Per Business Quant data, JNJ's Non Operating Interest Expenses in the three quarters before Q2 2026 was $272 million (Q1 2026), $214 million (Q4 2025) and $245 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn -
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 281.00 Mn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn -
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn -
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn -435.00 Mn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 247.00 Mn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 129.23 Bn 101.23 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 281.00 Mn
Mar 29, 2026 272.00 Mn
Dec 28, 2025 214.00 Mn
Sep 28, 2025 245.00 Mn
Jun 29, 2025 308.00 Mn
Mar 30, 2025 204.00 Mn
Dec 29, 2024 137.00 Mn
Sep 29, 2024 193.00 Mn
Jun 30, 2024 270.00 Mn
Mar 31, 2024 155.00 Mn
Dec 31, 2023 151.00 Mn
Oct 1, 2023 192.00 Mn
Jul 2, 2023 217.00 Mn
Apr 2, 2023 212.00 Mn
Jan 1, 2023 153.00 Mn
Oct 2, 2022 51.00 Mn
Jul 3, 2022 38.00 Mn
Apr 3, 2022 10.00 Mn
Oct 3, 2021 20.00 Mn
Jul 4, 2021 40.00 Mn
API Access

Johnson & Johnson Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=JNJ&period=max&api_key=YOUR_API_KEY